Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

1.08
Delayed Data
As of 3:07pm ET
 +0.01 / +0.93%
Today’s Change
0.71
Today|||52-Week Range
3.44
-12.20%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$22.3M

Company Description

Rosetta Genomics Ltd. develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies such as Rosetta Cancer Origin, mi-LUNG, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.

Contact Information

Rosetta Genomics Ltd.
10 Plaut Street
Rehovot Tel Aviv 76706
P:972732220700
Investor Relations:

Employees

Shareholders

Other institutional6.32%
Mutual fund holders0.22%
Individual stakeholders--

Top Executives

Kenneth A. BerlinPresident & Chief Executive Officer
Ron KalfusChief Financial Officer
Mats SandenDirector-Medical & Laboratory
Dganit BarChief Scientific Officer
Eti MeiriVice President-Research